Evidence map›Paper›PMID 30364932›Full record

ArticleBrain : a journal of neurology2018

Reply: TDP-43 mutations increase HNRNP A1-7B through gain of splicing function.

Martine Tétreault, Jade-Emmanuelle Deshaies, Sabrina Semmler, Hadjara Sidibé, Lulzim Shkreta, Kathryn Volkening, Hermona Soreq, Michael J Strong, Benoit Chabot, Christine Vande Velde

Abstract readLetterComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Brain : a journal of neurology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Martine TétreaultDepartment of Neurosciences, Université de Montréal, Montréal, QC, Canada.
Jade-Emmanuelle DeshaiesDepartment of Neurosciences, Université de Montréal, Montréal, QC, Canada.
Sabrina SemmlerCHUM Research Center, Montréal, QC, Canada.
Hadjara SidibéDepartment of Neurosciences, Université de Montréal, Montréal, QC, Canada.
Lulzim ShkretaDepartment of Microbiology and Infectious Diseases, Université de Sherbrooke, Sherbrooke, QC, Canada.
Kathryn VolkeningMolecular Medicine Research Group, Robarts Research Institute, London, ON, Canada.
Hermona SoreqThe Alexander Silberman Institute of Life Sciences, The Edmond and Lily Safra Center of Brain Science, The Hebrew University of Jerusalem, Israel.
Michael J StrongMolecular Medicine Research Group, Robarts Research Institute, London, ON, Canada.
Benoit ChabotDepartment of Microbiology and Infectious Diseases, Université de Sherbrooke, Sherbrooke, QC, Canada.
Christine Vande VeldeDepartment of Neurosciences, Université de Montréal, Montréal, QC, Canada.

Funding

CIHR MOP-136948
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Amyotrophic Lateral SclerosisHeterogeneous-Nuclear Ribonucleoprotein Group A-BAlternative SplicingDNA-Binding ProteinsHeterogeneous Nuclear Ribonucleoprotein A1HumansMutationRNA SplicingDNA-Binding ProteinsHeterogeneous Nuclear Ribonucleoprotein A1Heterogeneous-Nuclear Ribonucleoprotein Group A-BTARDBP protein, human

Identifiers

PMID30364932
PMCPMC6262216

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.